DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 2,335.00
+30.00 (1.30%)
Jul 21, 2026, 3:30 PM KST
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 74.68 billion as of July 21, 2026. Its market cap has decreased by -48.00% in one year.
Market Cap
74.68B
Enterprise Value
105.77B
Revenue
128.38B
Ranking
n/a
PE Ratio
8.58
Stock Price
2,335.00
ChartMarket Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 74.68B, a decrease of -62.73%. That is a compound annual growth rate of -50.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 74.68B | -36.20% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| iNtRON Biotechnology | 79.35B |
| PharmGen Science | 76.88B |
| Enzychem Lifesciences | 76.86B |
| Ray Co., Ltd. | 75.54B |